Own-brand peptide and GLP-1 stores

The claim

If you want to make money online, not sure why you wouldn’t sell peptides.

What do you think will sell better? A GLP or a fidget toy from Ali express?

Here’s how to build a peptide brand to 7 figures

THREAD

@King_Lou_IV, 3,023 views when collected¹

The thread advises a “research focused” website with disclaimers, and gives no price, cost or legal status¹². The page judges the scheme, not the person who tweeted.

The sums

A peptide is a short chain of amino acids. GLP-1 drugs such as semaglutide are prescription peptides used for weight loss²². The thread describes a web store selling vials labelled “for research use only”².

“Seven figures” means at least $1,000,000; we take it as a year’s sales¹. One lab’s price table for retatrutide, a peptide still in trials and not approved for anything²², shows two US-facing resellers charging $4.79 and $6.40 per milligram and six suppliers, mostly in China, charging $0.60 to $1.23³. These are its top-rated vendors, not a sample³. So a 10 mg vial costs about $6 to $12 and sells for about $48 to $64 (our sums from³). Then $1,000,000 takes 43 to 57 vials a day (our estimate from³).

After product, card fees, a share for affiliates (people paid to promote the product) and an assumed $5 of shipping, a $55 vial leaves about $28 to $33 (our estimate, from^311541920).

The margin is not the hard part. Card payments, finding customers and the law are, and the law decides the rest.

What happens to most people who try

We found no data on what share of these stores earn anything.

The US drug regulator, the FDA, says selling GLP-1 products with a “research” label is illegal²². It sent warning letters to five online peptide stores in August 2026, by two law firms’ count²⁶²⁷. A warning letter is the regulator’s statement, not a court finding.

Enforcement is uneven. Public Citizen, a consumer group, counted 14 FDA warning letters to sellers of one peptide since 2024; in May 2026, 11 of those companies were still advertising unapproved peptides⁵.

Payments are a second problem. One processor that serves peptide businesses states: “We do not support research-use-only (RUO) peptide sellers.”¹⁰

Prison is the rare outcome²⁹. One store’s owner was sentenced in July 2026 to 70 months, and CBS News reports that he admitted the store forged lab certificates²⁸²⁹.

Some stores do make money; see below.

The upside

Research-store route. Three small stores for sale on Flippa, a marketplace for online businesses, show monthly profit of $3,103 and $3,091 for two US stores and about US$16,000 for one selling to Australian customers (our conversion)⁷²⁷³⁷⁴. These are sellers’ listings, not audited accounts, and stores put up for sale are not a fair sample; all three owners are selling within 8 to 12 months⁷²⁷³⁷⁴. That is a realistic good result, with the legal exposure attached. One larger Flippa seller claims sales running at about $22 million a year nine months after launch, unverified⁵⁴.

Prescription route. A licensed clinician prescribes, a licensed pharmacy makes the drug to order (compounding), and the brand owner runs the website and adverts⁶⁴. MEDVi, started by one founder with about $20,000, reported $401 million of revenue and $65 million of profit in 2025⁶³. A newspaper checked those figures; they are not audited, and we could not open its article⁶³⁶⁴.

This route is legal with the right licences, but under pressure. In March 2026 the FDA announced warning letters to 30 telehealth companies (sellers of medical care over the internet) over how they marketed compounded GLP-1 drugs; one fault it named was branding the drug with the firm’s own name³³. Pharmacies could copy semaglutide freely while it was in shortage; that ended in 2025⁶⁹.

For a newcomer, our year-one estimate is a few hundred thousand dollars of revenue with little or no profit: a guess from³⁸ and⁴¹, not a measurement.

What it takes to compete

On the legal route, those who succeed have:

• Licences and certification first. A telehealth platform with a prescriber in each state, a payment processor that has approved the business, and certification by LegitScript, a private company that checks health sellers, which Meta requires for prescription-drug adverts¹³⁷⁶⁸. It costs $3,125 in the first year per website¹⁷. The real cost is advertising spent before it pays back, and legal advice: tens of thousands of dollars by our estimate, with no sourced figure.
• Proven advertising skill. Brands rent the same doctors and pharmacies, so advertising is the difference⁶⁴⁶⁸. Hims & Hers, a large telehealth company, spent 39 cents on marketing per dollar of sales in 2025 (our division)³⁸.

The research-store route is cheap to start: one freelancer builds a store for $8,000⁵⁸. Staying open depends on not being the next seller that regulators, card networks or drug makers (who have sued sellers) act against⁵⁴⁴³⁰.

How to tell early: can you name the licensed prescriber and pharmacy behind each sale? If not, you are on the route the FDA calls illegal²².

Who else makes money from it

The thread points to nothing for sale². Money goes to suppliers³; payment processors, about 7% of sales at one large store by its own listing⁵⁴; and affiliates, typically 10% of each sale¹⁹²⁰.

Every regulator and court action we found was against sellers, not those who taught or supplied them.